Ni J - Search Results

1

Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.

Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. Ni J, et al. J Exp Med. 2012 Dec 17;209(13):2351-65. doi: 10.1084/jem.20120944. Epub 2012 Dec 3. J Exp Med. 2012. PMID: 23209317 Free PMC article.

2

STAT5 Loss Awakens the Dark Force in Natural Killer Cells.

Ni J, Cerwenka A. Ni J, et al. Cancer Discov. 2016 Apr;6(4):347-9. doi: 10.1158/2159-8290.CD-16-0247. Cancer Discov. 2016. PMID: 27045017

3

Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors.

Pahl JHW, Cerwenka A, Ni J. Pahl JHW, et al. Among authors: ni j. Front Immunol. 2018 Nov 28;9:2796. doi: 10.3389/fimmu.2018.02796. eCollection 2018. Front Immunol. 2018. PMID: 30546366 Free PMC article. Review.

4

Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity.

Ni J, Galani IE, Cerwenka A, Schirrmacher V, Fournier P. Ni J, et al. Vaccine. 2011 Feb 1;29(6):1185-93. doi: 10.1016/j.vaccine.2010.12.005. Epub 2010 Dec 18. Vaccine. 2011. PMID: 21172381

5

Toward the next generation of NK cell-based adoptive cancer immunotherapy.

Ni J, Miller M, Stojanovic A, Cerwenka A. Ni J, et al. Oncoimmunology. 2013 Apr 1;2(4):e23811. doi: 10.4161/onci.23811. Oncoimmunology. 2013. PMID: 23734329 Free PMC article.

6

Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4⁺ T cell help.

Ni J, Hölsken O, Miller M, Hammer Q, Luetke-Eversloh M, Romagnani C, Cerwenka A. Ni J, et al. Oncoimmunology. 2016 Aug 5;5(9):e1219009. doi: 10.1080/2162402X.2016.1219009. eCollection 2016. Oncoimmunology. 2016. PMID: 27757318 Free PMC article.

7

Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity.

Ni J, Wang X, Stojanovic A, Zhang Q, Wincher M, Bühler L, Arnold A, Correia MP, Winkler M, Koch PS, Sexl V, Höfer T, Cerwenka A. Ni J, et al. Immunity. 2020 Jun 16;52(6):1075-1087.e8. doi: 10.1016/j.immuni.2020.05.001. Epub 2020 May 22. Immunity. 2020. PMID: 32445619 Free article.

8

Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence.

Ni J, Nolte B, Arnold A, Fournier P, Schirrmacher V. Ni J, et al. Vaccine. 2009 Sep 4;27(40):5480-7. doi: 10.1016/j.vaccine.2009.07.001. Epub 2009 Jul 17. Vaccine. 2009. PMID: 19616491

9

The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination.

Ni J, Schirrmacher V, Fournier P. Ni J, et al. Vaccine. 2010 Oct 4;28(42):6891-900. doi: 10.1016/j.vaccine.2010.08.011. Epub 2010 Aug 13. Vaccine. 2010. PMID: 20709006

10

Association Between Autoimmune Thyroid disease and Oral Lichen Planus: A Multi-Omic Genetic Analysis.

Ni J, Ye X, Chen Y, Fu H, Wu Z, Lu H, Chen Q. Ni J, et al. Int Dent J. 2024 Dec 30:S0020-6539(24)01634-4. doi: 10.1016/j.identj.2024.12.014. Online ahead of print. Int Dent J. 2024. PMID: 39741066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,133 results

Search Page

Filters